GHRS

GH Research PLC - Ordinary Shares (GHRS)

About GH Research PLC - Ordinary Shares (GHRS)

GH Research Plc is a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients with psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.

Details

Daily high

$19.88

Daily low

$18.32

Price at open

$19.69

52 Week High

$31.44

52 Week Low

$12.04

Market cap

1.4B

Dividend yield

Volume

407,250

Avg. volume

333,790

P/E ratio

-20.19

GH Research PLC - Ordinary Shares News